Loading...
XTSE
JWEL
Market cap1.20bUSD
Jul 10, Last price  
41.75CAD
1D
0.88%
1Q
21.40%
IPO
135.31%
Name

Jamieson Wellness Inc

Chart & Performance

D1W1MN
XTSE:JWEL chart
P/E
27.74
P/S
2.11
EPS
1.51
Div Yield, %
2.16%
Shrs. gr., 5y
0.82%
Rev. gr., 5y
15.29%
Revenues
822m
+12.03%
193,218,000230,865,000248,331,000300,619,000319,776,000344,980,000403,661,000451,032,000547,369,000676,172,000733,780,000822,056,000
Net income
62m
+20.27%
-33,176,000-95,382,000-25,166,000-23,787,00026,673,00031,657,00041,598,00052,082,00052,808,00047,882,00051,914,00062,437,000
CFO
83m
+33.99%
9,847,00018,009,00029,009,00017,845,00027,805,00016,396,00040,596,00044,405,00050,589,00031,713,00061,578,00082,509,000
Dividend
Dec 01, 20250.23 CAD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jamieson Wellness Inc. is a natural health products company involved in the development, manufacturing, marketing, and distribution of its offerings across Canada and internationally. The enterprise operates through two core segments. Its Jamieson Brands division focuses on human health products such as vitamins, herbal and mineral nutritional supplements, and over-the-counter remedies, marketed under the Jamieson and Lorna Vanderhaeghe labels. This segment also includes sports nutrition products sold under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides product development and manufacturing services on a contract basis to notable consumer health businesses and retailers. Jamieson Wellness Inc. reaches its customers through distributors, as well as retail and wholesale channels. Founded in 1922, the company, which adopted its current name in May 2017 after previously being known as Jamieson Intermediate Holdings Ltd., is based in Toronto, Canada.
IPO date
Jul 07, 2017
Employees
891
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT